JPRN-jRCTs071200042已完成未知
A double-blind placebo-controlled crossover study of Hesperidin from fermented Shekwasa (SHINJIMUN) on Peripheral Blood Perfusion
Inafuku Hitoshi0 个研究点目标入组 13 人开始时间: 2020年10月13日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 13
研究概览
简要总结
The present study examined the effect of hesperidin (SHINJIMUN) on peripheral blood flow in healthy subjects but found no effect of hesperidin on peripheral blood flow.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 70age old（—）
- 性别
- All
入选标准
- •1. Male and female patients, 20-70 years old
- •2. Written informed consent
- •3. For participants taking medications (including supplements and dietary supplements), those who have not changed their dosage and administration during the study period
排除标准
- •1. Renal dysfunction (eGFR<30ml/min/1.73m2)
- •2. Liver cirrhosis
- •3. Clinical evidence of cholestasis
- •4. Active cancer
- •5. Pregnant or lactating female
- •6. Participant deemed inadequate to this study
研究者
相似试验
已完成
3 期
Beneficial Impact of Orange Juice Consumption on Risk Factors Associated With Cardiovascular DiseasesCardiovascular Risk FactorsNCT02479568Technological Centre of Nutrition and Health, Spain159
Unknown
2 期
Vascular Effects of Hesperidin in Metabolic SyndromeEndothelial DysfunctionMetabolic SyndromeNCT00914251University of Rome Tor Vergata30
招募中
1 期
Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori InfectionHelicobacter Pylori InfectionNCT06546111Sadat City University46
已完成
3 期
A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.Symptomatic Decompensated Congestive Heart FailureCongestive Heart Failure in Acute Coronary SyndromeNCT00270374Scios, Inc.498
已完成
2 期
Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart FailureHeart FailureNCT00923156Novartis Pharmaceuticals123